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Abstract. Hypoplastic left heart syndrome (HLHS)
with a restrictive atrial septal defect (ASD) is a form
of congenital heart disease with considerable mor-
bidity and mortality. This morphologic analysis as-
sesses the pulmonary vasculature in this patient
population. Pulmonary arteries, the persistence of
high-resistance fetal arterioles, pulmonary veins, and
lymphatics from multiple lung sections from each of
five patients with HLHS and a restrictive ASD were
compared to those of five patients with HLHS and
nonrestrictive ASD. Lung sections from each patient
were qualitatively graded in severity of pathology
from 0 to 3 for each of the structures described pre-
viously, with the pathologist blinded to the status of
the ASD. Patients with a restrictive ASD exhibited
more significant pulmonary venous thickening and
lymphatic dilatation (p = 0.02), with a tendency to-
ward persistence of high-resistance fetal vessels (p =
0.2), compared to patients with a nonrestrictive ASD.
These findings imply that patients with HLHS and a
restrictive ASD possess pulmonary vascular abnor-
malities that place them at higher risk for the current
surgical interventions available compared to patients
with a nonrestrictive ASD.
Key words: Hypoplastic left heart syndrome —
Pulmonary vasculature — Atrial septal defect
Hypoplastic left heart syndrome (HLHS) is a form of
congenital heart disease consisting of aortic and/or
mitral atresia resulting in inadequate formation and
development of a functional left ventricle. The con-
dition in utero has little effect on the fetal circulation
because the right ventricle is the predominant source
of systemic blood flow via the ductus arteriosus.
Furthermore, systemic oxygenation is independent of
left ventricular output in utero because the supply of
oxygenated blood is delivered to the right heart via
the umbilical vein. Therefore, the absence of a left
ventricle has essentially no detrimental effect on fetal
circulation and hemodynamics.
Although blood flow via the pulmonary circula-
tion has been described to be minimal, accounting for
3% to 7% of the total right ventricular output [9], it
represents flow that returns to the left atrium. In
patients with mitral atresia or severe mitral stenosis,
decompression of this return of flow to the left atrium
must occur via the foramen ovale. The absence of an
adequate-sized foramen ovale likely results in left
atrial hypertension in utero, which is transmitted to
the pulmonary venous structures with resultant pul-
monary venous hypertension. It therefore seem
plausible that restriction of obligatory left-to-right
blood flow at the level of the atrial septum in patients
with HLHS would have deleterious consequences on
pulmonary vascular development.
Pulmonary vascular maldevelopment has signifi-
cant implications in HLHS because the current pal-
liative interventions necessitate a low pulmonary
resistance to ensure adequate pulmonary blood flow
via aortopulmonary shunts (i.e., Norwood proce-
dure) [11, 17] and, ultimately, cavopulmonary (i.e.,
hemi-Fontan and Fontan) connections [2, 16]. Fur-
thermore, cardiac transplantation remains a potential
treatment modality [4], the success of which is opti-
mized by normal pulmonary vasculature to prevent
post transplantation right ventricular failure. The
purposes of this study were to evaluate the pulmo-
nary vascular morphology in neonates with HLHS
and to determine if a restrictive atrial septal defect
(ASD) is associated with more severe pulmonary
vascular changes. We hypothesize that patients with
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restriction of left-to-right blood flow at the level of
the atrial septum demonstrate more severe pulmo-
nary vascular changes.
Methods
We retrospectively reviewed the echocardiography database from
January 1990 through September 1998 at the University of Michi-
gan Congenital Heart Center for patients with HLHS and normal
pulmonary venous return to the left atrium. HLHS was defined as
the presence of aortic and/or mitral atresia with a hypoplastic left
ventricle. Patients were then classified into two groups according to
the status of the atrial septum: First, a restrictive ASD was defined
as a mean spectral Doppler gradient of 8 mmHg or more from left
atrium to right atrium, across the atrial septum. The mean gradient
was measured during the entire cardiac cycle, over three to five
consecutive beats, without the use of angle correction, generally
from the subcostal views to best align the jet of left-to-right flow. A
gradient of 8 mmHg was arbitrarily chosen and agreed upon by all
the authors because it was believed to be a level of restriction that
was likely to be clinically significant and greater than that solely
attributable to excessive pulmonary blood flow. Second, a nonre-
strictive ASD was defined as a mean spectral Doppler gradient of 3
mmHg or less across the atrial septum. Excluded were patients with
a mean gradient between 3 and 8 mmHg because this is a range of
restriction that was believed to be influenced by the degree of
pulmonary blood flow. Also excluded were patients with an intact
atrial septum because this population of patients can often have
alternative decompression pathways from the left atrium, thereby
making determination of the left-to-right atrial gradient difficult
secondary to this decompression [1].
The pathology database of postmortem examination speci-
mens was also reviewed and the five most recent specimens of pa-
tients with HLHS and a restrictive ASD, as defined previously from
the echocardiography database, were chosen for pathologic review
of their pulmonary vasculature. The five most recent postmortem
examinations of patients with HLHS and a nonrestrictive ASD
were also selected for pathologic review and comparison of their
pulmonary vasculature.
Slides of pathologic specimens were qualitatively examined
with the pathologist blinded to the status of the atrial septum.
Three to six lung sections were reviewed from each lung for each
patient. At least one section from each lung was taken through the
hilum to ensure adequate assessment of the pulmonary venous
morphology. Sections were examined with H&E and elastic von
Gieson stains and were assessed for the following characteristics:
1. Pulmonary arterioles were assessed for the degree of medial
hypertrophy and were graded from 0 (normal) to 3 (marked
hypertrophy with muscular extension to the smaller arterioles).
2. Arteriolar morphology was also examined for the presence
and frequency of persistent fetal vessels. These are small,
hypertrophied, high-resistance vessels that often appear as a
‘‘knot-like’’ configuration on microscopic examination. They
are usually present at birth and generally resolve over the
course of a few days. Their persistence and abundance are often
indicative of elevated pulmonary artery pressures and are ab-
normal [6]. The frequency of these vessels was graded from 0
(no vessels noted) to 3 (vessels frequently seen in all the sections
examined).
3. Pulmonary veins were assessed for the degree of intimal fibrosis
and proliferation and were graded from 0 (normal) to 3
(markedly thickened intima with near obstruction of the vessel
lumen).
4. The lymphatic system was assessed and graded for the severity
of dilatation. The grade of severity between the two groups was
compared using Wilcoxon rank-sum tests to determine statis-
tical significance for the differences.
Results
Demographic data for the patients in nonrestrictive
and restrictive ASD groups are shown in Table 1. No
significant difference between them was noted with
regard to male-to-female ratio, mean birth weight,
mean gestational age, number of preoperative deaths,
age at the Norwood procedure, age at death, number
of postoperative deaths, and postoperative time until
death. No patient in either group underwent a pre-
operative atrial septostomy/septectomy, nor did any
of the patients have a decompression pathway for left
atrial egress.
The causes of death in the three preoperative
patients were an abrupt hypotensive episode with an
unsuccessful resuscitation in one patient (nonrestric-
tive ASD) and the withdrawal of support at request
Table 1. Patient characteristics
Characteristic Nonrestrictive ASD (n = 5) Restrictive ASD (n = 5)
Sex (Male:Female) 2:3 1:4
Cardiac pathology (MA/AA:MS/AA) 4:1 3:2
Birth weight (kg) 2.73 ± 0.48 2.67 ± 0.75
Gestational age (weeks) 39.2 ± 1.5 38.8 ± 1.9
Preoperative deaths 1 (3 days of age) 2 (2 and 4 days of age)
Age at Norwood (days) 8.6 ± 2.5 7.0 ± 4.2
Age of death (days) 9.4 ± 3.1 11.2 ± 5.0
Postoperative deaths 4 (0–3 days postop) 3 (0–16 days postop)
p > 0.05 for each of the clinical parameters, indicating no significant difference between the two groups. Data are presented as mean ±
SEM or as number of patients. AA, aortic atresia; MA, mitral atresia; MS, mitral stenosis.
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of the families due to severe hypoxemia and hemo-
dynamic instability in two patients (restrictive ASD).
Of the seven postoperative deaths, six were due to
sudden episodes of hypotension and bradycardia with
unsuccessful resuscitative efforts. One patient expe-
rienced an episode of unstable ventricular tachycar-
dia with an unsuccessful resuscitation.
Because the natural decrease in pulmonary vas-
cular resistance during the first few days of life results
in increased pulmonary blood flow, the gradient
across the ASD can potentially be influenced by the
age of the patient when the measurement was ob-
tained. Figure 1 demonstrates that despite the range
in age at which the echocardiograms were obtained in
the patients with restrictive ASDs (range = 1–23
days), the mean gradients across the atrial septa were
relatively constant and significantly elevated to cause
at least moderate left atrial hypertension in all five
patients. Furthermore, the two highest gradients
(15 and 16 mmHg) were obtained at 1 day of age
and four of the five patients were studied at less than
5 days of age, suggesting that older age and increased
pulmonary blood flow were not solely responsible
for the substantially elevated gradients in these
patients. There was no correlation between ASD size
as measured by echocardiogram (range 2.0–2.9 mm)
and mean gradient across the defect in patients with
restrictive ASDs, and all five patients had continuous
left-to-right flow throughout the cardiac cycle.
Histologic assessment with the pathologist
blinded to the status of the atrial septum demon-
strated abnormalities of the pulmonary arterioles in 7
of the 10 patients. Moderate pulmonary arteriole
thickening was seen in 3 patients in each of the two
groups with no significant difference between the
groups (Fig. 2A; p = 0.40). The frequency of per-
sistent fetal vessels was abnormal in 9 of the 10 pa-
tients, with a slightly higher frequency of persistence
in the restrictive ASD group (Fig. 2B; p = 0.12).
Although 3 patients in the restrictive ASD group
were 4 days old or younger, 2 of these patients in
fact had a lower frequency of fetal vessels than the 2
older patients who died at ages 23 and 24 days
(Fig. 2B).
Pulmonary venous abnormalities were observed
in 7 of the 10 patients. All patients in the restrictive
ASD group demonstrated abnormal venous thick-
ening and fibrosis, whereas only 2 patients in the
nonrestrictive group demonstrated abnormal pul-
monary veins (Fig. 2C; p = 0.02). Furthermore, 4 of
the 5 patients in the restrictive ASD group had at
least grade 2 venous thickening and 1 patient had
severe (grade 3) venous thickening and fibrosis with
near obstruction of the majority of veins. The severity
of lymphatic abnormalities mimicked those of the
pulmonary veins. Four of the 5 patients with a re-
strictive ASD demonstrated moderate lymphatic di-
latation and 1 patient had severe dilatation. In
contrast, 4 of the 5 patients with nonrestrictive de-
fects had normally lymphatics and 1 patient had
mildly dilated lymphatics (p = 0.02).
Discussion
Previous morphologic analyses of the pulmonary
vasculature have repeatedly demonstrated abnor-
malities of the pulmonary vascular bed in patients
with hypoplastic left heart syndrome [7, 8, 14]. These
abnormalities have generally been described as af-
fecting the pulmonary arteries and consist of in-
creased arterial medial thickness with muscular
extension to the smaller respiratory bronchioles.
Early observations suggested more severe abnormal-
ities in patients with closure of the foramen ovale
consisting of ‘‘intralobular pulmonary artery tortuo-
sity’’ and ‘‘pulmonary vein elastic hyperplasia’’ [7].
Decompression pathways from the left atrium to the
superior vena cava or right atrium have been ob-
served in this population as well, making determina-
tion of the degree of obstruction difficult solely on the
basis of the anatomic appearance of the atrial septum
[1]. A nearly intact atrial septum with an adequate
decompression vessel may in fact not result in
significant left atrial hypertension. Rychik et al. [18]
classified patients with HLHS and intact atrial sep-
tum according to atrial septal morphology, with
many patients demonstrating decompression path-
ways. Of those patients with obstructed decompres-
sion pathways, pulmonary arterial histopathology
was described as being no different from that of pa-
tients1 with HLHS and a widely patent ASD, whereas
pulmonary venous histopathology was described as
Fig. 1. The age of each patient with HLHS and a restrictive ASD
at the time of the echocardiogram is plotted with the corresponding
mean gradient across the atrial septal defect.
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thick and dilated with markedly dilated lymphatics,
more severe than in the control group.
Echocardiographic measurement of a mean
gradient from left atrium to right atrium across a
restrictive ASD provides quantitative evidence for
left atrial hypertension without the confounding
factor of a decompression pathway and therefore
serves as a model for determining the effects of in-
creased left atrial pressure on pulmonary vascular
development in this group of patients. Our findings
indicate that inadequate left atrial decompression
has mild effects on pulmonary arteriole development
Fig. 2. (A) Severity of pulmonary arteriolar medial thickening in the nonrestrictive ASD and restrictive ASD groups (p = 0.40). (B)
Frequency of persistent fetal vessels in the nonrestrictive ASD and restrictive ASD groups (p = 0.12). (C) Severity of pulmonary venous
thickening in the nonrestrictive ASD and the restrictive ASD groups (p = 0.02).
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with a dramatic consequence on pulmonary venous
and lymphatic development. Luciani et al. [13], in a
report of a single patient with congenital pulmonary
lymphagiectasis and hypoplastic left heart syndrome
with a restrictive ASD, likely described the most
severe spectrum of the lymphatic abnormalities de-
scribed in this study.
However, the long-term effects that these venous
and lymphatic changes have on long-term outcome
and whether the histopathologic abnormalities re-
solve are unknown. Long-term pulmonary pathologic
data for patients with HLHS and restrictive ASDs
are lacking. However, an analogous physiologic
condition in utero is that of the patient with ob-
structed total anomalous pulmonary venous connec-
tion (TAPVC) with resultant pulmonary venous
hypertension.Congenitalpulmonary lymphangiectasis
has been described in patients with obstructed TAP-
VC [5], similar to the case report by Luciani et al.
[13]. Furthermore, histopathologic analysis of lung
specimens from older infants following neonatal
repair of obstructed TAPVC has demonstrated
‘‘involvement of the pulmonary veins with medial
hypertrophy, intimal hypertrophy, and fibrosis,’’
even in patients as old as 6 month of age [15].
These data suggest that the pulmonary venous
abnormalities may persist at least until the typical
time of the second palliation with the hemi-Fontan
procedure.
Rychik et al. [18] reported a poor outcome for
patients with HLHS and a restrictive ASD following
the Norwood procedure. Although based on a small
group of patients, their data suggest that patients
surviving the Norwood procedure have a relatively
higher morbidity and mortality following cavopul-
monary connections, consistent with the fact that
these pulmonary vascular abnormalities may indeed
persist. Furthermore, animal models have shown
hyperreactivity of the pulmonary vasculature with
episodes of vasospasm after a period of in utero
pulmonary venous hypertension, thereby potentiat-
ing any lability in the pulmonary vascular resistance
and predisposing to episodic pulmonary hypertensive
crises [19]. The abnormalities of the pulmonary vas-
culature demonstrated in this study and the probable
vasospastic component of the vasculature certainly
pose a theoretical risk for patients ultimately requir-
ing a passive pulmonary circulation.
Severe cyanosis in the immediate neonatal period
in these patients obviously necessitates immediate
intervention with a surgical atrial septectomy or
balloon septostomy to ensure survival. Interestingly,
a recent survival analysis found no significant in-
crease in mortality in patients who underwent atrial
septostomy prior to the Norwood procedure [10],
which is contradictory to anecdotal experience and
data from earlier analyses [12, 18]. However, Canter
et al. [3] have shown patients with HLHS and a re-
strictive ASD to be at significantly higher risk for
death following transplantation compared to infants
with HLHS without a restrictive ASD. Regardless of
survival beyond the Norwood procedure, our mor-
phologic analysis implies that pulmonary vascular
abnormalities posing a significant physiologic risk
for later cavopulmonary connections or transplan-
tation are present in essentially all patients with
HLHS and a restrictive ASD. Therefore, it is plau-
sible to assume that mortality for this condition in
the near future, despite survival beyond the Nor-
wood procedure, will remain high without a good
option for transplantation or further cavopulmonary
palliation.
References
1. Bernstein HS, Moore P, Stanger P, Silverman NH (1995) The
levoatriocardinal vein: morphology and echocardiographic
identification of the pulmonary–systemic connection. J Am
Coll Cardiol 26:995–1001
2. Bove E (1998) Current status of staged reconstruction
for hypoplastic left heart syndrome. Pediatr Cardiol 19:308–
315
3. Canter CE, Moorehead S, Huddleston CB, Spray TL (1993)
Restrictive atrial septal communication as a determinant of
outcome of cardiac transplantation for hypoplastic left heart
syndrome. Circulation 88:II456–II460
4. Chiavarelli M, Gundry SR, Razzouk AJ, Bailey LL (1993)
Cardiac transplantation for infants with hypoplastic left heart
syndrome. J Am Med Assoc 270:2944–2947
5. France NE, Brown RJK (1971) Congenital pulmonary lym-
phangiectasis: report of 11 examples with special reference to
cardiovascular findings. Arch Dis Child 46:528–532
6. Geggel RL, Reid LM (1984) The structural basis of PPHN.
Clin Perinatol 2:525–549
7. Grant CA, Robertson B (1972) Microangiography of the
pulmonary arterial system in hypoplastic left heart syndrome.
Circulation 45:382–388
8. Haworth SG, Reid L (1977) Quantitative structural study of
pulmonary circulation in the newborn with aortic atresia,
stenosis, or coarctation. Thorax 32:121–128
9. Heyman MA (1995) Fetal and postnatal circulations: pulmo-
nary circulation. In: Emmanouilides GC, Riemenschneider
TA, Allen HD, Gutgesell HP (eds) Moss and Adams’ Heart
Disease in Infants, Children, and Adolescents, 5th edn. Williams
& Wilkins, Baltimore, pp 41–47
10. Jenkins PC, Flanagan MF, Jenkins KJ, et al (2000) Survival
analysis and risk factors for mortality in transplantation and
staged surgery for hypoplastic left heart syndrome. J Am Coll
Cardiol 36:1178–1185
11. Jonas RA, Lang P, Hansen D, Hickey P, Castaneda AR (1986)
First stage palliation for hypoplastic left heart syndrome.
J Thorac Cardiovasc Surg 92:6–13
12. Lloyd TR (1996) Prognosis of the hypoplastic left heart syn-
drome. Progr Pediatr Cardiol 5:57–64
13. Luciani GB, Pessotto R, Mombello A, Mazzucco A (1999)
Hypoplastic left heart syndrome with restrictive atrial septal
150 Pediatric Cardiology Vol. 23, No. 2, 2002
defect and congenital pulmonary lymphangiectasis. Cardiovasc
Pathol 8:49–51
14. Neumann MP, Heidelberger KP, Dick M, Rosenthal A (1980)
Pulmonary vascular changes associated with hypoplastic left
heart syndrome. Pediatr Cardiol 1:301–306
15. Newfeld EA, Wilson A, Paul MH, Reisch JS (1980) Pulmo-
nary vascular disease in total anomalous pulmonary venous
drainage. Circulation 61:103–109
16. Norwood WI, Jacobs ML (1993) Fontan’s procedure in two
stages. Am J Surg 166:548–551
17. Norwood WI, Lang P, Hansen DD (1983) Physiologic repair
of aortic atresia–hypoplastic left heart syndrome. N Engl J
Med 308:23–26
18. Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL
(1999) The hypoplastic left heart syndrome with intact atrial
septum: atrial morphology, pulmonary vascular histopathol-
ogy and outcome. J Am Coll Cardiol 34:554–560
19. Silove ED, Tavenor WD, Berry CL (1972) Reactive pulmo-
nary arterial hypertension after pulmonary venous constriction
in the calf. Cardiovasc Res 6:36–44
DOI: 10.1007/s00246-001-0063-6
Around PediHeart: Plastic Bronchitis
Over the past year or two there have been a number of interesting cases submitted to the PediHeart bulletin
board regarding a phenomena referred to in the literature and by PediHeart members as ‘‘plastic bronchitis’’.
I felt that this would be a good time for Around PediHeart to summarize those postings. When associated
with congenital heart disease ‘‘plastic bronchitis’’ is characterized by acellular fibromucinous bronchial casts
that cause symptomatic airway obstruction. Similar casts are also seen conditions that cause inflammation of
the bronchopulmonary tree but these casts tend to be made up of densely packed inflammatory (eosinophils)
cells [1].
There were 8 cases presented to the group. No cardiologist had more than one case. All instances of plastic
bronchitis occurred after a lateral tunnel type Fontan procedure with fenestration. For most patients the onset of
symptoms was roughly 2--3 years after the Fontan. For one patient it began 6 months post Fontan. Three
members included hemodynamic data. In one, the mean Fontan pressure was 13 mmHg with a wedge pres-
sure of 10 mmHg and a left ventricular end diastolic pressure (LVEDP) of 5 mmHg. This patient was 6 months
post Fontan and no therapy for the plastic bronchitis was successful including mucolytics, and Coumadin. The
second case with available data was 18 months post-op and had a Fontan pressure of 13 mmHg and an LVEDP
of 8 mmHg. Again no treatment was successful. The last case with data was several years post-op from his
Fontan. He had a mean Fontan pressure of 16--18 mmHg and an LVEDP of 8 mmHg. In this instance resolution
of plastic bronchitis occurred with aggressive medical treatment using continuous outpatient Milrinone infusion
to improve ventricular function and lower the Fontan mean pressure. While hemodynamic data was not
available for the other cases one had hypoalbuminemia and another had heart failure and protein losing
enteropathy a year after presenting with plastic bronchitis. In another case the plastic bronchitis occurred twice
after two subsequent non-cardiac surgeries years apart. Treatments temporally associated with improvement
included Milrinone infusion, thoracic duct ligation, steroid administration, cardiac transplantation, hepariniza-
tion, and doing nothing. Treatment failures included anticoagulation therapy with Coumadin, coil embolization
of pulmonary collateral vessels, inhaled mucolytics and bronchodilators, and doing nothing.
Plastic bronchitis is a real entity and, given that eight cardiologists from different centers posted a case
on PediHeart, it may not be so very rare. The mechanism for plastic bronchitis may involve an elevation in
systemic venous or pulmonary venous pressure [2]. This was the presumed cause behind the patient who
improved with Milrinone therapy and perhaps the patient who later developed protein losing enteropathy and
heart failure. It may also involve a primary abnormality in lymphatic drainage as suggested in the literature [1]
and by the patient who improved after thoracic duct ligation. Finally, given that in some patients plastic
bronchitis occurred and spontaneously resolved without reason or intervention, it would be safe to say that,
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